SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today an exclusive partnership with AccuRef Diagnostics, a Division of Applied StemCell, Inc., to market and sell their broad portfolio of CRISPR-engineered cell line reference materials.
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today the commercial launch of an expanded neurotrophic tropomyosin receptor kinase (NTRK) RNA fusion reference material panel developed in a partnership with Bayer.
Pioneering Survey of Clinical NGS QC Practices Proves Need for Purpose-Built QC Solutions to Standardize Industry
SeraCare Life Sciences has partnered with GenomeWeb to conduct a first-of-its-kind survey for clinical NGS labs with over 150 respondents providing comprehensive data detailing their QC management programs.
SeraCare Announces the Expansion of Their Proprietary AccuPlex™ Technology Product Portfolio with the Launch of the AccuSpan™ HCV RNA Linearity Panel
Announcing the launch of their all-new AccuSpan™ HCV RNA Linearity Panel – the latest product built with their proprietary AccuPlex™ recombinant technology
SeraCare Partners with NAVICAN on Implementation of Best-In-Class QC Workflow for TheraMap Precision Cancer Care™ Services
Leading NGS QC Software is integrated into their Philips IntelliSpace Genomics Platform
Comprehensive circulating tumor DNA reference materials for NGS assay development, validation, and daily run controls
SeraCare Announces Industry’s First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer
Truth-set NGS reference materials that broaden capabilities for tumor profiling assay validation and QC
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, today announced that Joe Bernardo has joined SeraCare’s board of directors in the role of Chairman
SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies
Truth-set NGS reference materials to significantly advance validation and QC of myeloid assays
SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing
Comprehensive suite of Zika IgM and recombinant Zika virus reference materials for method validation and evaluation of serological and molecular infectious disease assays.
Truth set ctDNA materials to significantly advance the development and validation of liquid biopsy assays
iQ NGS QC Management software provides clinical NGS labs the tools and analytics necessary to easily assess, maintain, and demonstrate assay performance
SeraCare Life Sciences announces launch of industry’s first multiplexed Inherited Cancer reference material
Expert-designed material for simplified validation of NGS-based panels
With Purified and FFPE formats, these standards are compatible with leading NGS-based Fusion RNA panels
In partnership with GenomeWeb, these live presentations bring together clinical genomics industry key opinion leaders to discuss practical examples and best practices
SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials
In partnership with Xtalks, this live webinar highlights a clinical laboratory case study
7-plex FFPE KRAS and updated RUO-GMP version of 40-plex Tumor Mutation DNA Mix now available
SeraCare Life Sciences to Support Non-Invasive Prenatal Testing (NIPT) Proficiency Program in Collaboration with UK NEQAS
Seraseq™ Aneuploidy Reference Materials to be used in one of the first widespread NIPT external quality assessment (EQA) programs
Firms will collaborate to support Archer® FusionPlex® NGS-assay customers
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is announcing the launch of the industry’s first multiplexed reference material for inherited disease testing by next-generation sequencing (NGS) at the 2016 ASHG Annual Meeting in Vancouver.